References
- Ricaurte GA, DeLanney LE, Irwin I, Langston JW. Toxic effects of MDMA on central serotonergic neurons in the primate: Importance of route and frequency of drug administration. Brain Res 1988; 446: 165–168
- Insel TR, Battaglia G, Johannessen JN, Marra S, De Souza EB. 3,4-Methylenedioxy-methamphetamine (“ecstasy”) selectively destroys brain serotonin terminals in rhesus monkeys. J Pharmacol Exp Ther 1989; 249: 713–720
- Schmidt, CJ. (1989). Acute and long-term neurochemical effects of methylenedioxymeth-amphetamine in the rat. In:. SJ Peroutka, editor. Ecstasy: The clinical, pharmacological and neurotoxicological effects of the drug MDMA. BostonMA: Kluwer Academic Publishers. p, 179–195.
- Battaglia G, Yeh SY, De Souza EB. MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons. Pharm Biochem Behav 1988; 29: 269–274
- McCann UD, Eligulashvili V, Ricaurte GA. 3,4-Methylenedioxymeth-amphetamine (“ecstasy”)-induced serotonin neurotoxicity: Clinical studies. Neuropsychobiology 2000; 42: 11–16
- Pennings EJ, Konijn KZ, de Wolff FA. Clinical and toxicologic aspects of the use of ecstasy. Ned Tijdschr Geneeskd 1998; 142: 1942–1946
- McCann UD, Slate SO, Ricaurte GA. Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; ‘ecstasy’). Drug Saf 1996; 15: 107–115
- Ricaurte GA, Yuan J, McCann UD. 3,4-Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’)-induced serotonin-neurotoxicity: Studies in animals. Neuropsychobiology 2000; 42: 5–10
- Diagnostic and statistical manual of mental disorders: DSM-IV. (1994). WashingtonDC: American Psychiatric Association.
- Schifano F. Potential human neurotoxicity of MDMA (‘Ecstasy’): subjective self-reports, evidence from an Italian drug addiction centre and clinical case studies. Neuropsychobiology 2000; 42: 25–33
- Bashir A, Swartz C. Alprazolam-induced panic disorder. J Am Board Fam Pract 2002; 15: 69–72
- Pallanti S, Mazzi D. MDMA (Ecstasy) precipitation of panic disorder. Biol Psychiatry 1992; 32: 91–95
- McCann UD, Ricaurte GA. MDMA (“Ecstasy”) and panic disorder: induction by single dose. Biol Psychiatry 1992; 32: 950–953
- Whitaker-Azmitia PM, Aronson TA. Ecstasy (MDMA)-induced panic. Am J Psychiatry 1989; 146: 119
- Maldonado E, Navarro JF. MDMA (‘ecstasy’) exhibits an anxiogenic-like activity in social encounters between male mice. Pharmacol Res 2001; 44: 27–31
- Sanchez V, Camarero J, Esteban B, Peter MJ, Green AR, Colado MI. The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA (‘ecstasy’)-induced degeneration of 5-HT nerve endings in rat brain. Br J Pharmacol 2001; 134: 46–57
- Parrott AC, Sisk E, Turner JJ. Psychobiological problems in heavy ‘ecstasy’ (MDMA) polydrug users. Drug Alcohol Depend 2000; 60: 105–110
- McCann UD, Eligulashvili V, Mertl M, Murphy DL, Ricaurte GA. Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users. Psychopharmacology (Berlin) 1999; 147: 56–65
- Gerra G, Zaimovic A, Ferri M, Zambelli U, Timpano M, Neri E, Marzocchi GF, Delsignore R, Brambilla F. Long-lasting effects of (+/ − )3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans. Biol Psychiatry 2000; 47: 127–136
- Ricaurte GA, Finnegan KT, Irwin I, Langston JW. Aminergic metabolites in cerebrospinal fluid of humans previously exposed to MDMA: Preliminary observations. Ann NY Acad Sci 1990; 600: 699–710
- McCann UD, Ricaurte GA. Lasting neuropsychiatric sequelae of (+/ − )3,4-methylenedioxymethamphetamine (‘ecstasy’) in recreational users. J Clin Psychopharmacol 1991; 11: 302–305
- Windhaber J, Maierhofer D, Dantendorfer K. Panic disorder induced by large doses of 3,4-methylenedioxymethamphetamine resolved by paroxetine. J Clin Psychopharmacol 1998; 18: 95–96
- Ricaurte GA, Martello AL, Katz JL, Martello MB. Lasting effects of (+/ − )3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in non-human primates: neurochemical observations. J Pharmacol Exp Ther 1992; 261: 616–622
- Simantov R, Tauber M. The abused drug MDMA (Ecstasy) induces programmed death of human serotonergic cells. FASEB J 1997; 11: 141–146
- De Souza EB, Battaglia G, Insel TR. Neurotoxic effects of MDMA on brain serotonin neurons: Evidence from neurochemical and radioligand binding studies. Ann NY Acad Sci 1990; 600: 682–698
- Work Group on Panic Disorder, American Psychiatric Association. Practice guideline for the treatment of patients with panic disorder. Am J Psychiatry 1999; 155(Suppl 5)1–34